Pembrolizumab for treatment of relapsed/refractory mycosis fungoides and Sezary syndrome: Clinical efficacy in a CITN multicenter phase 2 study Meeting Abstract
| Authors: | Khodadoust, M.; Rook, A. H.; Porcu, P.; Foss, F. M.; Moskowitz, A. J.; Shustov, A. R.; Shanbhag, S.; Sokol, L.; Shine, R.; Fling, S. P.; Li, S.; Rabhar, Z.; Kim, J.; Yang, Y.; Yearley, J.; Chartash, E. K.; Townson, S. M.; Subrahmanyam, P. B.; Maecker, H.; Alizadeh, A. A.; Dai, J.; Horwitz, S. M.; Sharon, E.; Kohrt, H.; Cheever, M. A.; Kim, Y. |
| Abstract Title: | Pembrolizumab for treatment of relapsed/refractory mycosis fungoides and Sezary syndrome: Clinical efficacy in a CITN multicenter phase 2 study |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446803144 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.181.181 |
| Notes: | Meeting Abstract: 181 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
